BDNF and major depressive disorder: The reported neurobiological changes in sgACC of MDD patients, such as brain atrophy (92), decreased neuronal size (93), and reduced neurotrophin activity (24), overall fit with the expected brain changes in the presence of excessive glucocorticoids.